Literature DB >> 17371866

Anti-Lewis X antibody promotes Helicobacter pylori adhesion to gastric epithelial cells.

Shew-Meei Sheu1, Bor-Shyang Sheu, Hsiao-Bai Yang, Huan-Yao Lei, Jiunn-Jong Wu.   

Abstract

Lewis X (Le(x)) antigen is expressed on the human gastric mucosa and the O-specific chain of lipopolysaccharides of Helicobacter pylori. This antigen can induce autoantibodies, which may be involved in bacterial colonization and thus deserve further investigation. Flow cytometry was used to examine the effects of anti-Le monoclonal antibodies (MAbs) on H. pylori adhesion. A babA2 mutant was also constructed to evaluate the effect of an anti-Le(x) MAb on adhesion. The bacterial agglutination and in situ adhesion assays were used to confirm the anti-Le(x) MAb effect on H. pylori adhesion. This study revealed that an anti-Le(x) MAb, but not an anti-Le(b) MAb or an anti-Le(y) MAb, could enhance the adhesion of H. pylori strains that expressed high levels of Le(x) antigen to AGS cells. The enhancement was not found on an H. pylori strain with a low level of Le(x) antigen. Anti-Le(x) MAb could increase the adhesion of both the wild-type strain and its isogenic babA2 mutant to AGS cells. When AGS cells were pretreated with anti-Le(x) MAb, the adhesion of the babA2 mutant also increased. Only anti-Le(x) MAb could promote bacterial agglutination, and the in situ adhesion assay further confirmed that adding anti-Le(x) MAb resulted in denser bacterial adhesion on the gastric epithelia collected from clinical patients. These results suggest anti-Le(x) MAb could specifically enhance the adhesion abilities of H. pylori strains through a mechanism by which anti-Le(x) MAb promotes bacterial aggregation and mediates bivalent interaction (antigen-antibody-antigen) between bacteria and host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371866      PMCID: PMC1932895          DOI: 10.1128/IAI.01689-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions.

Authors:  G O Aspinall; M A Monteiro
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

2.  Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions.

Authors:  G O Aspinall; M A Monteiro; H Pang; E J Walsh; A P Moran
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

3.  Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms.

Authors:  M A Monteiro; K H Chan; D A Rasko; D E Taylor; P Y Zheng; B J Appelmelk; H P Wirth; M Yang; M J Blaser; S O Hynes; A P Moran; M B Perry
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

4.  Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status.

Authors:  H P Wirth; M Yang; M Karita; M J Blaser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Construction of a Helicobacter pylori-Escherichia coli shuttle vector for gene transfer in Helicobacter pylori.

Authors:  W K Lee; Y S An; K H Kim; S H Kim; J Y Song; B D Ryu; Y J Choi; Y H Yoon; S C Baik; K H Rhee; M J Cho
Journal:  Appl Environ Microbiol       Date:  1997-12       Impact factor: 4.792

6.  Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide.

Authors:  I M Simoons-Smit; B J Appelmelk; T Verboom; R Negrini; J L Penner; G O Aspinall; A P Moran; S F Fei; B S Shi; W Rudnica; A Savio; J de Graaff
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.

Authors:  D Ilver; A Arnqvist; J Ogren; I M Frick; D Kersulyte; E T Incecik; D E Berg; A Covacci; L Engstrand; T Borén
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

Review 8.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

9.  Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients.

Authors:  D E Taylor; D A Rasko; R Sherburne; C Ho; L D Jewell
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

10.  Establishment and characterisation of a monoclonal antibody to inhibit adhesion of Helicobacter pylori to gastric epithelial cells.

Authors:  T Osaki; H Yamaguchi; H Taguchi; M Fukuda; H Kawakami; H Hirano; S Watanabe; A Takagi; S Kamiya
Journal:  J Med Microbiol       Date:  1998-06       Impact factor: 2.472

View more
  4 in total

1.  The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin.

Authors:  Marija Pinne; Henry A Choy; David A Haake
Journal:  PLoS Negl Trop Dis       Date:  2010-09-07

2.  Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection.

Authors:  Ruo-Yi Xue; Mu-Fei Guo; Ling Guo; Chang Liu; Sun Li; Jiao Luo; Li Nie; Lu Ji; Cong-Jia Ma; Da-Qun Chen; Si Sun; Zhe Jin; Quan-Ming Zou; Hai-Bo Li
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

Review 3.  Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.

Authors:  Jacek Baj; Alicja Forma; Monika Sitarz; Piero Portincasa; Gabriella Garruti; Danuta Krasowska; Ryszard Maciejewski
Journal:  Cells       Date:  2020-12-25       Impact factor: 6.600

4.  Influence of monoclonal anti-Lewis b, anti-H type 1, and anti-sialyl Lewis x antibodies on binding of Helicobacter pylori to MUC1 mucin.

Authors:  I Radziejewska; K Leszczyńska; M Borzym-Kluczyk
Journal:  Mol Cell Biochem       Date:  2013-10-06       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.